Thanks, Greg, and good morning, everyone. Let’s turn to the earnings highlights on slide 5. Our reported second quarter earnings per share was $4.09 compared to $1.34 in the second quarter of 2022. Our reported results included a positive mark-to-market timing difference of $0.59 per share and a negative impact of $0.22 per share related to one-time items. Adjusted EPS was $3.72 in the quarter versus $2.97 in the prior year. Adjusted core segment earnings before interest and taxes, or EBIT, was $893 million in the quarter versus $709 million last year. Agribusiness adjusted results of $674 million were up compared to last year. In processing, higher results in the quarter reflected better year-over-year performance across all value chains, driven in part by strong Brazil soybean origination, which contributed to higher crush results in Brazil and our destination crush operations in Europe and Asia. In the U.S., results were also higher as we entered the quarter with a significant portion of our capacity locked in at higher margins. In merchandising, higher results in global oils and grains were more than offset by lower results in our financial services and ocean freight operations, which had difficult comparisons to a particularly strong prior year. Refined and Speciality oils continued its trend of strong performance though results were slightly lower than last year. Our results in North America driven by food service and fuel demand were offset by slightly lower results across Europe, South America and Asia. In Milling, low results in the quarter were primarily driven by our South American operations, which were negatively impacted by the small Argentine wheat crop. Segment results in the prior year benefited from effective risk management of our supply chains during a period of high market volatility. The increase in corporate expenses in the quarter primarily reflected planned investments in growth and productivity related initiatives that will pay off in future periods. Lower other results related to our captive insurance program and Bunge Ventures. Results on our non-core sugar and bioenergy joint venture included a $39 million benefit from the reversal of evaluation allowance. In addition, improved results reflected higher sugar prices that more than offset lower ethanol prices. Adjusting for notable items, net interest expense is $78 million in the quarter was down slightly compared to last year, as higher average variable rates were offset by higher interest income. For the six months of the year, income tax expense was $381 million compared to $144 million in the prior year. The increase was primarily due to higher pre-tax income in 2023, as well as a change in geographic earnings mix. Let’s turn to slide 6 where you can see our adjusted EPS and EBIT trends over the past four years, along with the trailer 12 months. Our team continues to deliver excellent performance, especially when considering the rapidly changing market conditions we have faced, while also executing on a variety of internal initiatives to improve our capabilities. Slide 7 details our capital allocation of the approximately $1.4 billion of adjusted funds from operations that we have generated year-to-date. After allocating $181 million to sustaining CapEx, which includes maintenance, environmental health and safety, we had approximately $1.2 billion of discretionary cash flow available. Of this amount, we paid $180 million in common dividends, and invested $360 million in growth and productivity related CapEx, leaving approximately $630 million in retain cash flow. We have not purchased any shares this year as a result of our discussions to combine with Viterra. However, we recently announced that our board has expanded our existing share repurchased program to $2 billion. We want to be in the market as soon as possible, and we expect that a meaningful portion of these repurchases will be executed prior to the close of the Viterra transaction, with remainder to be completed within 18 months of that date. As shown in Slide 8, at quarter-end Readily-Marketable Inventories, or RMI, exceeded our net debt by approximately $3.6 billion. This reflects our use of retained cash flow to fund working capital while reducing debt. Slide 9 highlights our liquidity position. At quarter-end all $5.7 billion of our committed credit facilities was unused and unavailable, providing a sample liquidity to manage our on-going capital needs. And working with our key banking partners, we also recently secured $8 billion in the form of term loan commitments to fund our combination with Viterra. Please turn to Slide 10. The trailing 12 months suggested ROIC was 20.3%, well above our RMI adjusted weighted average cost to capital 7.7%. ROIC was 15.1%, also well above our weighted average cost to capital 7%. Moving to Slide 11, for the trailing 12 months, we produced discretionary cash flow of approximately $2.1 billion and a cash flow yield of 19.2%. Please turn to Slide 12 and our 2023 outlook. As Greg mentioned in his remarks, taking into account the first half of the year results and the current margin environment in four curves, we have increased our full year 2023 adjusted EPS outlook to at least $11.75 per share. In Agribusiness, full year results are forecasted to be down from last year, though slightly better than our prior outlook, as higher results in processing are more than offset by low results in merchandising. However, depending on how market conditions evolve over the remainder of the year, there could be upside to our segment outlook. In Refined Specialty Oils, full year results are expected to be up from our prior outlook and in line with last year’s record performance. In Milling, full year results are expected to be lower than our prior outlook and significantly down from a strong prior year. In Corporate and other results are expected to be in line with last year. In Non-Core full year results in our sugar and bioenergy joint venture are expected to be in line with the last year. Additionally, the company expects the following for 2023; an adjusted annual effective tax rate in the range of 20% to 24%, net interest expense in the range of $350 million to $370 million dollars, which is down from our prior outlook of $360 million to $390 million. Capital expenditures in the range are $1 billion to $1.2 billion, which is up to $200 million from our prior outlook reflecting the purchase of a U.S. oil refinery during the second quarter and depreciation amortization of approximately $415 million. With that, I’ll turn things back over to Greg for some closing comments.